Vietnam warns of food supply disruptions as African swine fever spreads, Asia News
Vietnam has this year detected 514 outbreaks in 28 out of 34 cities and provinces nationwide, the government said in a statement, adding that the authorities have culled more than 30,000 infected pigs.
"The risk of African swine fever is on a rising trend, negatively affecting the pig farming industry, food supplies and the environment," the government said.
African swine fever has disrupted the global pork market for years. In the worst outbreak over 2018 to 2019, about half the domestic pig population died in China, the world's biggest producer, causing losses estimated at over US$100 billion (S$130 billion).
The recent outbreaks in Vietnam have prompted Prime Minister Pham Minh Chinh to send an urgent directive to provinces and government agencies this week to deploy measures to curb the disease.
Vietnam in 2023 approved the domestic commercial use of its first home-grown African swine fever vaccines, but officials said the rate of vaccinated pigs remains low.
"Only around 30 per cent of the pigs in my province have been vaccinated," said an animal health official of Quang Ngai province, where infections have been reported over the past few weeks.
"It's not clear why the rate is low — it could either be the issue of vaccine availability, efficiency or cost," said another provincial official, who declined to be named as the person is not authorised to speak to the media.
The agriculture ministry's Department of Animal Health didn't respond to Reuters' request for comment. Calls to AVAC Vietnam JSC, the country's main African swine fever vaccine producer, went unanswered.
AVAC said last month it had sold 3 million vaccine doses in the domestic market and exported 600,000 doses to the Philippines and Indonesia.
[[nid:716724]]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
International Business Times
44 minutes ago
- International Business Times
Vietnam Marks Medical Breakthrough With First Robotic Pediatric Brain Procedure
Robotic systems are fast becoming the new standard worldwide. According to Frontiers, the global medical robots market was valued at approximately US$27.7 billion in 2023, and is projected to hit US$127 billion by 2033, growing at a CAGR of 16.5%. Europe and North America remain leaders in adoption. In 2023, Europe alone had over 3,500 surgical robotic systems and performed more than 280,000 robotic surgeries, according to MarketGrowthReports. "Innovation like robot-assisted surgery isn't science fiction, it's the future of the health service," said UK Health Secretary Wes Streeting in The Scottish Sun. That future is no longer limited to the West. It has arrived in Southeast Asia, specifically, Vietnam. At Vinmec Central Park International Hospital (Ho Chi Minh City), surgeons performed the country's first pediatric stereo-electroencephalography (SEEG) using the AutoGuide™ robotic guidance system on a 9-year-old boy with drug-resistant epilepsy. The patient, B.Q.K. from Hanoi, had suffered from epilepsy since 2021. Despite undergoing multiple treatments in Vietnam and abroad, his seizures persisted. For five years, his family sought a solution that could restore their son's quality of life and allow for seizure-free sleep. That solution arrived in 2025. On June 17, 2025, a surgical team led by Dr. Truong Van Tri, with support from Japanese epilepsy expert Assoc. Prof. Dr. Shunsuke Nakae, performed a high-precision resection. The young patient after a life-changing breakthrough Handout Using AutoGuide, Vinmec doctors successfully implanted electrodes deep into the orbitofrontal cortex and inferior frontal gyrus—regions densely packed with neural networks and blood vessels. The robot worked in tandem with advanced imaging tools, including a 3.0 Tesla MRI and multi-channel EEG systems, to visualize the brain and track seizure activity. These technologies allowed the clinical team to identify the epileptogenic zone with high confidence, something that conventional surface EEG, PET, or MRI alone often fail to do in pediatric cases. "For the first time, we achieved near-perfect outcome in pediatric epilepsy surgery thanks to AutoGuide™. This is a critical milestone, especially for young patients who are highly vulnerable to major brain surgery," said Dr. Tri. The patient experienced no postoperative neurological deficits. Within a month, he returned to regular play, and his seizure frequency decreased by more than 95%, a life-changing turnaround. New Hope for Drug-Resistant Epilepsy Patients According to the World Health Organization, approximately 30% of epilepsy patients are drug-resistant, meaning they do not respond to medication. Surgery is often the most effective option for these patients, but it relies heavily on accurately localizing the epileptogenic zone. This process becomes even more difficult in children, where traditional tools like scalp EEG, MRI, and PET often yield inconclusive results. Robotic SEEG offers a minimally invasive and highly accurate alternative. Vinmec Central Park advances neurology through technology and international integration By combining robotic precision with multidisciplinary expertise, Vinmec Central Park is now among the few hospitals in Asia capable of performing pediatric SEEG with robotic assistance. Recognized as Vietnam's top private hospital system for expatriates and international patients (based on independent surveys), Vinmec is advancing the frontiers of neurology and precision medicine in Southeast Asia. This achievement reflects Vinmec's long-term strategy to develop centers of excellence through cutting-edge technology, personalized treatment, and global collaboration. As Vietnam continues to invest in AI, robotics, and precision healthcare, such milestones offer new possibilities for patients once deemed untreatable.
Straits Times
3 hours ago
- Straits Times
Artificial sweetener consumption linked to less effective cancer treatment: Study
Sign up now: Get ST's newsletters delivered to your inbox In the study, high consumption of sucralose was linked with lower effectiveness of immunotherapies across a range of cancer types, stages and treatment methods. In patients with melanoma or non-small cell lung cancer, consuming high levels of the artificial sweetener sucralose contributes to diminished responses to immunotherapy and poorer survival, researchers reported in Cancer Discovery. When the researchers had 132 patients with advanced melanoma or non-small cell lung cancer answer detailed diet history questionnaires, they found that high consumption of sucralose was linked with lower effectiveness of immunotherapies across a range of cancer types, stages and treatment methods. In experiments with mice, the researchers found that sucralose shifts the composition of microbes in the intestines, increasing bacterial species that degrade arginine, an amino acid that is essential for key immune cells called T cells. 'When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly,' study leader Abby Overacre of the University of Pittsburgh said in a statement. 'As a result, immunotherapy wasn't as effective in mice that were fed sucralose.' Laying the groundwork for a solution to the problem, the same researchers also found in the mice that supplements that boosted levels of arginine mitigated the negative effects of sucralose on immunotherapy, an approach they now hope to test in humans. 'It's easy to say 'stop drinking diet soda', but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic,' Assistant Professor Overacre said. 'That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.' REUTERS
Straits Times
6 hours ago
- Straits Times
Artificial sweetener consumption linked to less effective cancer treatment
Sign up now: Get ST's newsletters delivered to your inbox High consumption of sucralose was linked with lower effectiveness of immunotherapies across a range of cancer types, stages and treatment methods. In patients with melanoma or non-small cell lung cancer, consuming high levels of the artificial sweetener sucralose contributes to diminished responses to immunotherapy and poorer survival, researchers reported in Cancer Discovery. When the researchers had 132 patients with advanced melanoma or non-small cell lung cancer answer detailed diet history questionnaires, they found that high consumption of sucralose was linked with lower effectiveness of immunotherapies across a range of cancer types, stages and treatment methods. In experiments with mice, the researchers found that sucralose shifts the composition of microbes in the intestines, increasing bacterial species that degrade arginine, an amino acid that is essential for key immune cells called T cells. 'When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly,' study leader Abby Overacre of the University of Pittsburgh said in a statement. 'As a result, immunotherapy wasn't as effective in mice that were fed sucralose.' Laying the groundwork for a solution to the problem, the same researchers also found in the mice that supplements that boosted levels of arginine mitigated the negative effects of sucralose on immunotherapy, an approach they now hope to test in humans. 'It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic,' Overacre said. 'That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.' REUTERS
